Selected Publications

Nikhil Yegya-RamanTimothy P. KegelmanSang Ho LeeMichael J. KallanKristine N. KimJyotsna NatarajanMatthew P. DeekWei ZouShannon E. O’ReillyZheng ZhangWilliam LevinKeith CengelGary KaoRoger B. CohenLova L. SunCorey J. LangerCharu AggarwalAditi P. SinghRupal O’QuinnBonnie KyAditya ApteJoseph DeasyYing XiaoAbigail T. BermanSalma K. JabbourSteven J. Feigenberg: Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer. Clinical and Translational Radiation Oncology 39: 100581, Mar 2023.

Nikhil Yegya-Raman, Steven Feigenberg, John Kucharczuk, Bonnie Ky, Lova Sun: Cardiovascular Risk Mitigation with Lung Cancer Treatment. Current Oncology Reports 25: 433-444, Feb 2023.

Sun L, Marmarelis M, Aggarwal C: Re-evaluating Real World Evidence in RET fusion-positive NSCLC – are Randomized Clinical Trials needed? Journal of Thoracic Oncology 18(5): 549-551, May 2023 Notes: DOI: 10.1016/j.jtho.2023.02.001

Lova Sun, Benjamin Bleiberg, Wei-Ting Hwang, Melina E Marmarelis, Corey J Langer, Aditi Singh, Roger B Cohen, Ronac Mamtani, Charu Aggarwal. : Association between duration of immunotherapy and overall survival in advanced non-small cell lung cancer. JAMA Oncology 9(8): 1075-1082. Aug 2023.

Sun L, Ky, Bonnie. : Cardiovascular risk and events in US Veterans with head and neck squamous cell carcinoma. JAMA Otolaryngology Head Neck Surg 149(8): 717-725, Aug 2023.

Melina Marmarelis, Lova Sun, Charu Aggarwal: Controversies in Thoracic Oncology: adjuvant atezolizumab should be given to all patients with PD-L1 positive tumors. JTO DOI: https://doi.org/10.1016/j.jtho.2021.02.002, 16(3): 366-367, Mar 2023.

Hobday SB, Brody RM, Kriegsman B, Basu D, Newman J, Cohen RB, Lukens JN, Singh A, D'Avella CA, Sun L.: Outcomes Among Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors. JAMA Otolaryngol Head Neck Surg 148: 918-926, Oct 2022.

Sun L, Candelieri-Surette D, Anglin-Foote T, Lynch JA, Maxwell KN, D'Avella C, Singh A, Aakhus E, Cohen RB, Brody RM.: Cetuximab-Based vs Carboplatin-Based Chemoradiotherapy for Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg 148(11): 1022-1028, Nov 2022.

Lova Sun, MD, MSCE; Melina Marmarelis, MD; and Charu Aggarwal, MD, MPH: First-Line Therapy in Patients With KRAS-Mutated Non–Small Cell Lung Cancer. ASCO Daily News Sep 2022 Notes: https://dailynews.ascopubs.org/do/first-line-therapy-patients-kras--mutated-non-x2013-small-cell-lung-cancer

Sun L, Brody R, Candelieri D, Anglin-Foote T, Lynch JA, Maxwell KN, Damrauer S, Ojerholm E, Lukens JN, Cohen RB, Getz KD, Hubbard RA, Ky B: Association Between Up-front Surgery and Risk of Stroke in US Veterans With Oropharyngeal Carcinoma. JAMA Otolaryngol Head Neck Surg. 148(8): 740-747, Aug 2022.